Header cover image

U.S. Healthcare Sector Analysis

UpdatedDec 01, 2021
DataAggregated Company Financials
Companies1608
  • 7D-1.7%
  • 3M-6.7%
  • 1Y12.9%
  • YTD8.1%

Over the last 7 days, the Healthcare industry has dropped 1.7%, driven by a pullback from Merck of 9.5%. Meanwhile, Moderna actually outperformed within the industry, gaining 28% in the last week. This takes the industry's 12 month performance to a gain of 13%.

Sector Valuation and Performance

Has the U.S. Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Wed, 01 Dec 2021US$6.6tUS$2.4tUS$146.5b30.6x
Fri, 29 Oct 2021US$6.8tUS$2.3tUS$127.3b34x
Sun, 26 Sep 2021US$6.9tUS$2.3tUS$120.1b36.1x
Tue, 24 Aug 2021US$6.9tUS$2.3tUS$121.2b33.3x
Wed, 30 Jun 2021US$6.6tUS$2.3tUS$113.6b32.4x
Sat, 03 Apr 2021US$6.0tUS$2.4tUS$93.5b29x
Tue, 05 Jan 2021US$5.8tUS$2.3tUS$87.0b29.3x
Fri, 09 Oct 2020US$5.1tUS$2.3tUS$104.6b28.7x
Thu, 02 Jul 2020US$4.8tUS$2.4tUS$101.2b31.4x
Sun, 05 Apr 2020US$3.9tUS$2.4tUS$99.2b28.8x
Wed, 08 Jan 2020US$4.5tUS$2.3tUS$100.0b29.1x
Tue, 01 Oct 2019US$3.8tUS$2.3tUS$84.2b26.2x
Fri, 05 Jul 2019US$4.0tUS$2.2tUS$96.2b28.2x
Mon, 08 Apr 2019US$3.9tUS$2.1tUS$84.5b28x
Thu, 10 Jan 2019US$3.7tUS$2.0tUS$68.5b25x
PE Ratio

27.8x

Total Market Cap: US$4.0tTotal Earnings: US$59.1bTotal Revenue: US$2.0t0%0%0%3 Year10 Year
201920202021

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 30.0x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Healthcare industry have grown 35% per year over the last three years, and revenues for these companies have grown 6.6% per year. This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.S. Healthcare sector?

Biotech1.27%
Life Sciences0.73%
Healthtech-0.84%
Pharma-3.03%
Healthcare Services-3.56%
Medical Equipment-3.67%

Industry PE: Investors are most optimistic about the Healthtech industry which is trading above its 3-year average PE ratio of 67.0x. This is likely because analysts are expecting annual earnings growth of 34%, which is higher than its past year's earnings growth of 17% per year. Meanwhile, investors are most pessimistic about the Healthcare Services industry, which is trading close to its 3-year average of 20.3x.

Forecasted Growth: Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 34% over the next 5 years. This is better than it's past earnings growth rate of 17% per year. Meanwhile, the Life Sciences industry is expected to see its earnings grow by 7.8% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

Company7D1YValuation
MRNA Moderna27.5%+US$30.8b149.9%PE20.2x
PFE Pfizer5.2%+US$14.9b36.3%PE15.4x
BNTX BioNTech13.9%+US$10.4b208.5%PE10.1x
DHR Danaher2.6%+US$5.8b43.0%PE40.8x
ADGI Adagio Therapeutics155.2%+US$3.2bn/aPB8.3x
Simply Wall St
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

PFE

US$53.73

Pfizer

7D

5.2%

1Y

36.3%

ABBV

US$115.28

AbbVie

7D

-3.0%

1Y

10.8%

CI

US$191.90

Cigna

7D

-10.0%

1Y

-7.5%